A carregar...

The focal adhesion kinase inhibitor PF-562,271 impairs primary CD4+ T cell activation

The focal adhesion kinase inhibitor, PF-562,271, is currently in clinical development for cancer, however it is not known how PF-562,271 affects T cell function. Here, we demonstrate inhibitory effects of PF-562,271 on the activation of primary human and mouse T cells. PF-562,271 inhibits T cell rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wiemer, Andrew J., Wernimont, Sarah A., Cung, Thai-duong, Bennin, David A., Beggs, Hilary E., Huttenlocher, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3762933/
https://ncbi.nlm.nih.gov/pubmed/23928188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2013.07.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!